A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes.

Trial Profile

A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of Interferon Beta-1a Manufactured by Two Different Processes.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2015

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Glioma; Hepatitis B; Hepatitis C; Human papillomavirus infections; Multiple sclerosis
  • Focus Pharmacokinetics
  • Sponsors Biogen Idec
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
    • 12 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top